279 related articles for article (PubMed ID: 11408923)
1. Expression of galectin-3-reactive ligands in squamous cancer and normal epithelial cells as a marker of differentiation.
Plzák J; Smetana K; Hrdlicková E; Kodet R; Holíková Z; Liu FT; Dvoránkova B; Kaltner H; Betka J; Gabius HJ
Int J Oncol; 2001 Jul; 19(1):59-64. PubMed ID: 11408923
[TBL] [Abstract][Full Text] [Related]
2. Galectin-3, an endogenous lectin, as a tool for monitoring cell differentiation in head and neck carcinomas with implications for lectin-glycan functionality.
Betka J; Plzák J; Smetana K; Gabius HJ
Acta Otolaryngol; 2003 Jan; 123(2):261-3. PubMed ID: 12701754
[TBL] [Abstract][Full Text] [Related]
3. Correlation of expression of nuclear proteins pKi67 and p63 with lectin histochemical features in head and neck squamous cell cancer.
Chovanec M; Smetana K; Betka J; Plzák J; Brabec J; Moya-Alvarez V; André S; Kodet R; Gabius HJ
Int J Oncol; 2005 Aug; 27(2):409-15. PubMed ID: 16010422
[TBL] [Abstract][Full Text] [Related]
4. Differentiation-dependent glycosylation of cells in squamous cell epithelia detected by a mammalian lectin.
Plzák J; Holíková Z; Smetana K; Dvoránková B; Hercogová J; Kaltner H; Motlík J; Gabius HJ
Cells Tissues Organs; 2002; 171(2-3):135-44. PubMed ID: 12097836
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of desmosomes in oral squamous cell carcinoma: correlation with cytokeratin and E-cadherin staining, and with tumour behaviour.
Shinohara M; Hiraki A; Ikebe T; Nakamura S; Kurahara S; Shirasuna K; Garrod DR
J Pathol; 1998 Apr; 184(4):369-81. PubMed ID: 9664902
[TBL] [Abstract][Full Text] [Related]
6. Nucleostemin expression in squamous cell carcinoma of the head and neck.
Cada Z; Boucek J; Dvoranková B; Chovanec M; Plzák J; Kodets R; Betka J; Pinot GL; Gabius HJ; Smetana K
Anticancer Res; 2007; 27(5A):3279-84. PubMed ID: 17970071
[TBL] [Abstract][Full Text] [Related]
7. Galectin-3 upregulation during tumor progression in head and neck cancer.
Saussez S; Decaestecker C; Mahillon V; Cludts S; Capouillez A; Chevalier D; Vet HK; André S; Toubeau G; Leroy X; Gabius HJ
Laryngoscope; 2008 Sep; 118(9):1583-90. PubMed ID: 18677282
[TBL] [Abstract][Full Text] [Related]
8. Concomitant increases in galectin-1 and its glycoconjugate ligands (carcinoembryonic antigen, lamp-1, and lamp-2) in cultured human colon carcinoma cells by sodium butyrate.
Ohannesian DW; Lotan D; Lotan R
Cancer Res; 1994 Nov; 54(22):5992-6000. PubMed ID: 7954433
[TBL] [Abstract][Full Text] [Related]
9. A novel marker for basal (stem) cells of mammalian stratified squamous epithelia and squamous cell carcinomas.
Samuel J; Noujaim AA; Willans DJ; Brzezinska GS; Haines DM; Longenecker BM
Cancer Res; 1989 May; 49(9):2465-70. PubMed ID: 2468409
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of alpha2,3/2,6-linked N-acetylneuraminic acid and cytokeratin expression in head and neck squamous cell carcinoma.
Chovanec M; Plzák J; Betka J; Brabec J; Kodet R; Smetana K
Oncol Rep; 2004 Aug; 12(2):297-301. PubMed ID: 15254692
[TBL] [Abstract][Full Text] [Related]
12. Deregulated Bag-1 protein expression in human oral squamous cell carcinomas and lymph node metastases.
Hague A; Packham G; Huntley S; Shefford K; Eveson JW
J Pathol; 2002 May; 197(1):60-71. PubMed ID: 12081206
[TBL] [Abstract][Full Text] [Related]
13. Galectin-3 - an emerging prognostic indicator in advanced head and neck carcinoma.
Plzák J; Betka J; Smetana K; Chovanec M; Kaltner H; André S; Kodet R; Gabius HJ
Eur J Cancer; 2004 Oct; 40(15):2324-30. PubMed ID: 15454259
[TBL] [Abstract][Full Text] [Related]
14. Expression of galectins in head and neck squamous cell carcinoma.
Gillenwater A; Xu XC; el-Naggar AK; Clayman GL; Lotan R
Head Neck; 1996; 18(5):422-32. PubMed ID: 8864733
[TBL] [Abstract][Full Text] [Related]
15. Carcinoembryonic antigen and other glycoconjugates act as ligands for galectin-3 in human colon carcinoma cells.
Ohannesian DW; Lotan D; Thomas P; Jessup JM; Fukuda M; Gabius HJ; Lotan R
Cancer Res; 1995 May; 55(10):2191-9. PubMed ID: 7743523
[TBL] [Abstract][Full Text] [Related]
16. Expression of component desmosomal proteins in uterine endometrial carcinoma and their relation to cellular differentiation.
Nei H; Saito T; Tobioka H; Itoh E; Mori M; Kudo R
Cancer; 1996 Aug; 78(3):461-70. PubMed ID: 8697392
[TBL] [Abstract][Full Text] [Related]
17. Cervical lymph node involvement in head and neck cancer detectable as expression of a spliced transcript of type II keratin K5.
McDonald LA; Walker DM; Gibbins JR
Oral Oncol; 1998 Jul; 34(4):276-83. PubMed ID: 9813723
[TBL] [Abstract][Full Text] [Related]
18. E-cadherin is a selective and strongly dominant prognostic factor in squamous cell carcinoma: a comparison of E-cadherin with desmosomal components.
Bosch FX; Andl C; Abel U; Kartenbeck J
Int J Cancer; 2005 May; 114(5):779-90. PubMed ID: 15609307
[TBL] [Abstract][Full Text] [Related]
19. Colon cancer mucin: a new ligand for the beta-galactoside-binding protein galectin-3.
Bresalier RS; Byrd JC; Wang L; Raz A
Cancer Res; 1996 Oct; 56(19):4354-7. PubMed ID: 8813123
[TBL] [Abstract][Full Text] [Related]
20. Galectin-7: will the lectin's activity establish clinical correlations in head and neck squamous cell and basal cell carcinomas?
Cada Z; Chovanec M; Smetana K; Betka J; Lacina L; Plzák J; Kodet R; Stork J; Lensch M; Kaltner H; André S; Gabius HJ
Histol Histopathol; 2009 Jan; 24(1):41-8. PubMed ID: 19012243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
